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Multiple isozymes of cyclic  nucleotide phosphodies- 
terases (PDEs) are expressed  simultaneously in mam- 
malian tissues. To identify and clone these PDEs, a 
polymerase  chain  reaction  (PCR)  strategy  was devel- 
oped using degenerate oligonucleotide primers de- 
signed  to  hybridize  with  highly  conserved  PDE DNA 
domains. Both known and novel PDEs were cloned 
from  rat liver,  the mouse K30a-3.3  lymphoma  cell  line, 
and a  human  hypothalamus cDNA library,  demonstrat- 
ing  that  these PCR primers  can  be used to amplify the 
cDNA of multiple PDE isozymes. One unique mouse 
PDE clone was found to encode a polypeptide  identical 
with  the  corresponding  portion f the bovine brain 63- 
kDa calmodulin-dependent PDE as reported in the 
companion article (Bentley, J. K., Kadlecek, A., Sher- 
bert, C. H., Seger, D., Sonnenburg, W. K., Charbon- 
neau, H., Novack, J. P., and Beavo, J. A. (1992) J. 
Biol. Chem. 267,18676-18682).  This mouse clone was 
used as a  probe  to  screen  a rat  brain cDNA library  for 
a full-length clone. The conceptual translation of the 
nucleotide  sequence of the  resulting rat clone has  an 
open  reading  frame of 636 amino  acids  and  maintains 
a high degree of homology with  the bovine 63-kDa 
calmodulin-dependent  PDE,  indicating that  this  pro- 
tein is likely to be the rat homolog of the 63-kDa 
calmodulin-dependent PDE. Expression of the full- 
length clone in Escherichia coli yielded a cGMP hydro- 
lyzing  activity  that  was  stimulated  severalfold  by cal- 
modulin. Northern blot  analysis  demonstrated that  the 
mRNA encoding this PDE is highly  expressed  in rat 
brain  and also in the 549.1 T-lymphocyte cell line. 
These  data  demonstrate hat  the PCR method described 
is a viable strategy  to  isolate cDNA clones of known 
and novel  members of different  families of PDE iso- 
zymes. Molecular  cloning of these  PDEs  will  provide 
valuable tools for  investigating  the  roles of these iso- 
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zymes in  regulation of intracellular  concentrations of 
the cyclic nucleotides. 
Cyclic nucleotide phosphodiesterases (PDEs)’ catalyze the 
hydrolysis of the 3’,5’  cyclic nucleotides, cAMP and cGMP, 
to  the corresponding nucleoside 5‘-monophosphates. These 
cyclic nucleotides are intracellular second messengers in a 
variety of endocrine and neural cells. In concert with changes 
in  the  rate of cyclic nucleotide synthesis, modulation of  cyclic 
nucleotide degradation by PDEs regulates the intracellular 
concentration of these second messengers and controls the 
activity of these cells. Multiple different PDEs are  simulta- 
neously expressed and differentially regulated in mammalian 
tissues and single cell types (1,2). However, the physiological 
significance of this complexity in PDE expression is unknown. 
The mammalian PDEs are classified by their biochemical 
properties into five families (1, 3, 4). Calmodulin-dependent 
PDEs (CaM-PDEs, family I) are stimulated by a calcium- 
calmodulin complex. The cGMP-stimulated PDEs (cGS- 
PDEs, family 11) are allosterically activated by cGMP. The 
cGMP-inhibited PDEs (cGI-PDEs, family 111) are  inhibited 
by cGMP and cardiac inotropic drugs such as milrinone. The 
CAMP-specific PDEs (CAMP-PDEs, family IV) have high 
affinity for cAMP  alone and  are inhibited by  RO 20-1724 and 
the antidepressant, rolipram. The cGMP-specific PDEs 
(cGMP-PDEs, family V) have high affinity for cGMP alone. 
Each family has multiple members, but  their relatively low 
abundance,  similar kinetic properties, and extreme sensitivity 
to proteolysis have complicated their characterization and, 
even, their enumeration. Recently, molecular techniques have 
aided these  studies but have revealed new levels of complexity. 
Some members of the  CaM-PDE  and cGS-PDE families have 
had full or partial amino acid microsequences determined (5- 
8). Some members of the CAMP-PDE, cGMP-PDE, and, 
recently, the  cGS-PDE families have had their cDNAs molec- 
ularly cloned (9-19). Northern blots have demonstrated the 
simultaneous presence of mRNA for multiple, nearly identical 
isozymes of PDEs in many tissues (12). These isozymes are 
encoded by distinct genes in some cases and  alternate splicing 
from a single gene in other cases (12, 13). Neither amino acid 
nor nucleic acid sequences have yet been reported for any 
member of the cGI-PDE family, and no nucleic acid sequences 
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have been reported for members of the  CaM-PDE families. 
Three isozymes of the family I CaM-PDEs have been 
isolated from the brain (20). The predominant brain isozyme 
(61 kDa), which is also expressed in  small amounts in  many 
other tissues, has been shown to be an  alternate splice product 
of the gene which encodes the predominant, 59-kDa heart 
isozyme (6, 21). A unique gene encodes a 63-kDa CaM-PDE 
that  has been detected only in  brain  and phytohemagglutinin- 
stimulated,  but  not quiescent, T-lymphocytes (20, 22). A 75- 
kDa  brain isozyme has  not been fully characterized (20). 
To enable investigation of the role of multiple PDEs  in 
regulation of intracellular cyclic nucleotide concentrations, 
we attempted  to characterize the full range of PDEs present 
in cells and tissues by a  PCR-based molecular cloning tech- 
nique. Comparison of the known or deduced amino acid 
sequences for seven PDEs from four mammalian PDE fami- 
lies plus the Drosophila dunce PDE (11) and  the high affinity 
Saccharomyces PDE (23) reveals a central conserved domain 
(5, 12) of approximately 250 amino acids that is likely to 
contain the catalytic site (7, 24). Within this domain are 
several smaller regions (up  to 7 amino acids) of stringently 
conserved sequence. We designed degenerate PCR primers 
that hybridize with the nucleic acid coding sequences for these 
regions and used these  primers to identify and clone PDEs 
from several mammalian tissues. One novel rat cDNA ob- 
tained by this approach encodes a  CaM-dependent PDE  that 
is expressed in brain  and in  a T-lymphocyte cell line. Evidence 
is presented that  this cDNA encodes the  rat 63-kDa CaM- 
PDE isozyme. Bentley et al. (25) in the companion article 
report the isolation of a homologous cDNA encoding the 
bovine brain 63-kDa CaM-PDE. 
EXPERIMENTAL PROCEDURES 
Cell Lines-The S49.1 mouse lymphoma cell line was obtained 
from the American Type Culture Collection (ATCC No. TIB 28). 
The S49.1 subline, K30a-3.3,  which has increased cGI-PDE activity 
compared with the wild type (26), was a generous gift of H. R.  Kaslow 
(University of Southern California, Los Angeles). The cells were 
grown in suspension in Dulbecco’s  modified  Eagle’s medium-H 
(GIBCO) supplemented with 10% horse serum (JRH Biosciences, 
Lenexa, KS) and harvested by centrifugation at a density of lo6 cells/ 
ml. 
cDNA Production-Standard molecular biological procedures were 
used throughout these experiments. Poly(A)+ RNA  was isolated from 
29-day-old Sprague-Dawley rat liver and from S49.1 and K30a-3.3 
cells by homogenization in guanidinium thiocyanate buffer, ultracen- 
trifugation through cesium chloride, and fractionation with oligo(dT)- 
cellulose (Collaborative Research, Bedford, MA) by standard proce- 
dures (27, 28). cDNA was synthesized from 1 pg of poly(A)+ RNA 
using 0.5 pg of random primer and 200 units of Moloney murine 
leukemia virus reverse transcriptase (GIBCO) in a total volume of  20 
pl, according to  the supplier’s protocol. A human hypothalamus cDNA 
library in Xgtll (generous gift of R. Goodman, Tufts University, 
Boston, MA)  was  used as a source of human cDNA. 
PDE cDNA  Analysis-Two degenerate, oppositely oriented, oligo- 
nucleotide PCR primers were designed (Fig. 1) based on actual nucleic 
acid sequences and nucleic acid sequences deduced from the most 
probable codons (29) for the amino acid sequences in two highly 
conserved regions of a variety of PDEs ( 5 ,  12). Primer PDE-5’ is 
comprised of a mixture of 128 different possible combinations of the 
alternative nucleotides indicated at each position in Fig. 1. Likewise, 
primer PDE-3’ is a mixture of  384 different primer species. To 
facilitate cloning, an EcoRI endonuclease recognition site was added 
to  the 5‘ end of PDE-5’, and a SalI site was added to  the 5’ end of 
PDE-3‘. Approximately 350 base pairs (bp) of PDE sequence fall 
between the extents of the hybridization sites for these primers. 
PCR was performed on liver and K30a-3.3 cDNA by diluting a 20- 
pl reverse transcription reaction to 100 p1 in PCR buffer to obtain 17 
mM Tris  (pH 8.3), 50 mM KCl, 2 mM MgCl,,  0.14 mM each ultrapure 
dNTP (Pharmacia LKB Biotechnology Inc.), 2 mM dithiothreitol, 
100 pg/ml acetylated bovine serum albumin, and primers PDE-5’ and 
PDE-3’ at final concentrations of 4 and 10 p ~ ,  respectively. The 
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FIG. 1. Design of degenerate PCR primers for amplification 
of PDE isozymes. The central conserved domain of amino acid 
sequence of PDEs is indicated by the shaded portion of the cartoon 
of a typical PDE  at  the top of the figure. The amino acid sequences 
of two short, highly conserved regions of the nine PDEs listed at  the 
left are indicated in the center of the figure. These regions are 103 
amino acids apart in all listed PDEs except 104 amino acids apart in 
the bovine cGS-PDE. The degenerate PCR primers listed at the 
bottom of the figure (PDE-5’, left, and PDE-3’, right) were derived 
from the known nucleotide sequence of the cloned PDEs or the most 
likely nucleotide sequence of those PDEs with known protein se- 
quence. RatPDEl, RatPDE2, RatPDE3, and RatPDE4 are CAMP- 
PDEs cloned from rat testes (12). Dunce PDE is a  CAMP-PDE cloned 
from Drosophila (11,15). Bovine CUM PDE is the 61-kDa CaM-PDE 
from bovine brain (7), and Bovine cGS PDE is a cGS-PDE from 
bovine heart (8). Bovine retina PDE is the CY subunit of a rhodopsin- 
sensitive cGMP-PDE cloned from bovine retina  (17). Yeast PDE is 
the high affinity CAMP PDE cloned from Saccharomyces (23). 
mixture was heated to 94 “C for 3 min before addition of five units of 
AmpliTaq DNA Polymerase (Perkin-Elmer Cetus) and cycling 40 
times at 94 “C for 1 min, 55 “C for 2 min, and 72 “C for 3 min. Human 
hypothalamus PDE cDNAs  were PCR-amplified directly from a X g t l l  
cDNA library. 
After digestion with SalI and EcoRI and electrophoresis in 3% 
NuSieve Agarose (FMC Bioproducts, Rockland, ME), the PCR frag- 
ments of approximately 350 bp were isolated and ligated into  SalI- 
and EcoRI-digested M13  mp18 phage DNA (GIBCO). One-hundred 
clones were screened by performing dideoxy-GTP chain termination 
sequencing reactions (30) and grouping the clones according to  the 
pattern of resulting “G-ladder” bands on a  denaturing sequencing gel. 
From each group a limited number of clones was selected for complete 
sequencing. 
RNA Analysis-Poly(A)+ RNA prepared from tissues or cultured 
cells was glyoxylated and fractionated by electrophoresis through a 
1% agarose gel and transferred to a  Biotrans nylon membrane (ICN, 
Costa Mesa, CA) (31). DNA probes were generated by PCR using the 
degenerate PDE primers, PDE-5’ and PDE-3’, and an M13 mp18 
template containing a cloned PDE cDNA fragment. Probes were 
labeled by random priming (Boehringer Mannheim) in the presence 
of [32P]dCTP,  and hybridization was performed in 50% formamide at 
42 “C with washing in 0.1 X SSC at 65 “C. 
Isolation of Full-length PDE Clone-Two Xgtll libraries were 
screened. The Crb series of clones were isolated from a commercial 
library (Clontech RL1002R, Palo Alto,  CA) of oligo(dT)- andrandom- 
primed cDNA from entire  adult Sprague-Dawley rat brain. The Arb 
clones were isolated from a library (generous gift of J. Arriza, Duke 
University) constructed of oligo(dT)-primed cDNA from the entire 
brain of 6-week-old Sprague-Dawley rats. These libraries were 
screened using a  PCR-generated  PDE cDNA probe. Clones obtained 
were plaque purified and subcloned into the EcoRI site of the plasmid 
pBS+ (Stratagene, La Jolla, CA). These double-stranded plasmids 
were completely sequenced in both directions, using 11 sequencing 
primers from within the  PDE sequence plus flanking vector primers. 
Bacterial Expression of PDE Clone-PDE cDNA from Arb 5, a 
Xgtll clone, was subcloned into the bacterial expression vector pET3b 
(32). The vector was digested with NdeI and BamHI, dephosphoryl- 
ated with calf intestinal alkaline phosphatase (Boehringer Mann- 
heim), and purified from trace  contamination with uncut plasmid by 
electrophoresis in 1% agarose. Using PCR, a NdeI restriction endo- 
nuclease site was added to  the 5’ terminus and a BamHI site was 
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added  to  the 3' terminus of the  open  reading  frame of the  PDE  cDNA 
encoded in Arb 5. This  PCR  fragment was  ligated into  the  prepared 
vector.  MAX  Efficiency DH5aF'IQ  competent Escherichia coli 
(GIBCO) were transformed and selected by growth in ampicillin- 
containing medium. Plasmid isolates  with inserts of the  appropriate 
size,  plus  pET3b vector without a cDNA insert, were used to  trans- 
form  E. coli BLZl(DE3)pLysS.  the expression  host. Twenty-ml cul- 
tures were grown to mid-log phase,  and isopropyl-8-D-thiogalactopyr- 
anoside  (IPTG) was  added to 0.4 mM to  initiate  transcription of the 
cDNA  insert. 2.5 h later,  aliquots were harvested by centrifugation 
and resuspended in 20 mM Tris  (pH €LO) ,  1 mM sodium EDTA,  and 
600 pg/ml lysozyme. After a 5-min  incubation  on ice, a mixture of 
protease  inhibitors was added  (13),  and  PDE  assays were  performed 
according to  the  method of Thompson  and  Appleman  (33)  using 1 
p~ ['HIcGMP and  the  extract from 4.5 X 10' cells. Assays performed 
in the presence of calmodulin contained 500 ng/ml  calmodulin 
(Sigma)  and 2 mM CaCI2. 
RESULTS 
Design and Use of Degenerate PCR Primers to  Amplify PDE 
cDNAs-To isolate PDE cDNAs, PCR was performed using 
template cDNA from several mammalian sources with the 
degenerate PCR primers, PDE-5'  and PDE-3'. These  primers 
were designed to hybridize to two highly conserved regions 
(approximately 350 bp apart) in PDE cDNAs. PCR products 
of  350  bp length were recovered, subcloned into M13 mp18, 
screened by examination of G-ladder band  patterns,  and  then 
each  distinct clone type was fully sequenced. Using rat liver 
template, five different clones were retrieved. Four of these 
are identical to the cDNA of the four rat CAMP-PDEs 
(ratPDE1,  ratPDE2,  ratPDE3,  and  ratPDE4)  that were pre- 
viously cloned from rat testes (12). The fifth clone likely 
encodes a novel rat cGS-PDE as its deduced amino acid 
sequence is 99% identical to  the corresponding portion of a 
bovine cGS-PDE (5). Characterization of this cDNA will  be 
the subject of a  subsequent publication. 
From K30a-3.3  mouse lymphoma cell cDNA, two distinct 
clones were isolated. One is likely to encode the mouse hom- 
olog of the  rat CAMP-PDE, ratPDE3,  as  it  has 94% nucleotide 
sequence identity (and 99% deduced amino acid identity) with 
the corresponding portion of the cDNA for ratPDE3 (12) 
(data not shown). The  other K30a-3.3 mouse clone, named 
K-17, was found to encode an amino acid sequence 70% 
identical with the corresponding amino acid sequence of the 
catalytic domain of the bovine 61-kDa CaM-PDE  (5) (Fig. 2). 
Recent further nucleic acid sequence data (25) reveal that  the 
deduced amino acid sequence of the mouse K-17 clone is 100% 
identical (while the nucleic acid sequence is 91% identical) 
with the corresponding portion of the bovine 63-kDa CaM- 
PDE (data not shown, sequences deposited in GenBank). 
Thus,  this clone is likely to be a  partial clone of the  rat 63- 
kDa CaM-PDE. 
From a  human  hypothalamus cDNA library, three  distinct 
clones were isolated. One, named hh37, encodes 95% amino 
acid (Fig. 2) and  has 91% nucleotide sequence identity  with 
the mouse K-17 clone and probably represents the human 
homolog of the 63-kDa CaM-PDE.  A second clone has high 
nucleotide sequence identity with the rat cGS-PDE clone 
described above and  thus is likely to represent  a  human cGS- 
PDE  (data not shown). The  third clone isolated was found to 
have 91% nucleotide sequence identity with a rat CAMP- 
PDE,  ratPDE2  (data  not shown) and probably represents the 
human clone corresponding to  this  rat PDE. 
Distribution of RNA Transcripts of the K-17 PDE  in  Rat 
Tissues and S49.1 Cell Line-The tissue  distribution of 
expression of mRNA for the K-17 PDE was investigated by 
Northern blot analysis. Poly(A)+ RNAs from rat  brain,  heart, 
liver, kidney, and testis were hybridized with a radiolabeled 
mouse K-17 probe (Fig. 3). A transcript of approximately 3.0 
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FIG. 2. Comparison of partial amino acid sequences of CaM- 
PDEs from four different species. Mouse  CUM is deduced from 
clone K-17. Human CaM is deduced from clone hh37. Rat CUM is 
amino acid  residues 221-336 deduced  from  clone  Arb 5. Bouine 6ICaM 
is  amino acid  residues 217-332  of the 61-kDa CaM-PDE of Charbon- 
neau et al. (7). The  amino acid  sequence of this  portion of the 63- 
kDa CaM-PDE of Bentley et al. (25) is identical to  Rat CaM. An 
asterisk  indicates an  amino acid  identical to  that  of the mouse CaM. 
Lines  above and below the sequences indicate  the region of the  PCR 
primers used to clone the  PDEs  and were excluded  from  numerical 
comparisons of the sequences presented  in  the  text. 








FIG. 3. Detection of CaM-PDE transcripts in various rat 
tissues and 549.1 cell lines by Northern blot. Five pg of poly(A)+ 
RNA isolated  from brain,  heart, liver, and kidney of 90-day-old rats, 
testes of 29-day-old rats, and S49.1 and K30a-3.3 cell lines were 
hybridized with a '"P-labeled mouse CaM-PDE probe and  autoradi- 
ographed.  Size markers  are  HindIII-digested X-DNA fragments. 
kb was detected in the rat brain, but no transcript was 
detected in  any of the  other tissues. Poly(A)+ RNA was also 
isolated from S49.1 cells, a mouse lymphoma cell line, with 
T-lymphocyte characteristics (34, 35), and from K30a-3.3 
cells, which are derived from the S49.1 line (26). These 
poly(A)+ RNAs hybridized with the K-17 probe producing a 
strong signal a t  about 7.0 kb and weaker signals at  4.4 and 12 
kb (Fig. 3). In  contrast  to  rat  CAMP-PDE transcripts, which 
have wide tissue  distribution (12, 13), and  the  rat cGS-PDE 
transcripts, which are detected in all rat tissues examined 
(brain, heart, liver, kidney, and testis, data not shown), K-17 
transcripts  are relatively restricted  in their tissue distribution, 
here  demonstrated to be expressed only in brain and  the T- 
lymphoma cell line. 
A Full-length Rat cDNA  Clone Encoding a Polypeptide  with 
Sequence Homologous  to the Bovine  CaM-PDEs-Because K- 
17 transcripts were found to be abundant in rat brain, the K- 
17 probe was used to screen two different rat brain cDNA 
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libraries  constructed  in Xgtll. Screening of the Arriza library 
yielded one clone, Arb  5, that includes an insert of 3.0 kb with 
an open reading frame of 1815 bp beginning with an ATG 
within  a Kozak consensus sequence and preceded by an in- 
frame stop codon (Fig. 4). Five additional clones, Arb 1-5, 
each greater than 1.2 kb in length, were subsets of Arb 5. 
Screening of the Clontech library yielded six clones, each 
under 900 bp in length. Five of these clones, Crb 1-5, contain 
overlapping portions of a sequence identical to Arb 5. The 
sixth clone, Crb 6, has a 3' portion with sequence identical to 
Arb 5  but has a completely divergent 5' sequence. This clone 
may represent an alternate splice product and will be the 
subject of a subsequent report. There is 95% nucleotide se- 
quence identity between the mouse K-17 probe and  the cor- 
responding portion of the  rat Arb 5 clone, and  they encode 
only one amino acid difference (Fig. 2). 
The nucleic acid sequence and deduced amino acid sequence 
of the coding portion of Arb 5 is presented in Fig. 4. Compar- 
ison of these rat nucleic acid sequences with those recently 
reported for the bovine 63-kDa CaM-PDE (25) reveals 97% 
amino acid and 89% nucleic acid sequence identity,  and thus 
this clone likely encodes a rat 63-kDa CaM-PDE. Comparison 
of the deduced amino acid sequence of the Arb 5 clone with 
the amino acid sequence of the bovine 61-kDa CaM-PDE  (7) 
reveals considerable homology but only 57% overall identity. 
Expression of the Arb 5 Clone in Bacteria Demonstrates a 
CaM-stimulated PDE Actiuity-The  DNA fragment consist- 
ing of the open reading frame of the Arb 5 clone with a NdeI 
restriction  site at  the 5' terminus and a  BamHI  restriction 
site  at  the 3' end was produced by PCR using the Arb 5 clone 
as template. This  fragment was subcloned into  the expression 
vector pET3b (32), and two isolates (9  and 16) were trans- 
formed into E. coli BL21(DE3)pLysS. This vector/host sys- 
ACCCCTGCTiiCCTTGGGCCGlirCCCRGRCRCRCCGGCCTGGCTAGTCCACGCCAGCCGCA 
GIICGGTGGCTGI\GC*TGGIGCTGTCCCCCCGCliCrCCTCCAGAGATGCTGGAGTCGGATT 1 2 0  
M E L S P R S P P E H L E S O  15 
G C C C G T C I C C C C T G G A G C T G M G T C A G C C C C C A G C M G M G A ~ ~ ~ ~ ~ ~ ~ ~ M ~ ~ ~ * ~ = = ~  
C P S P L E L K S I P S K K M W I K L R  
C T C T G C T G C G C T I C I T G G T G M G C A G T T G G A G M T G G G G A G = T T M = ~ T = ~ A ~ ~ ~ ~ ~ ~ ~ *  2 4 0  
X - G ~ C C T G G M T A ~ A C A G C T T C C C T G C T G G M G C T G T ~ T A = A T T = A T = * = ~ = M ~ ~ ~  
S L L R Y M V R Q L E N C E V N I E E L  5 5  
RRRTCTTGGACACTGMGATGAGCTTCCCCAACTTCCGTCAGATGCCGTGCCTTCAGAGG 3 6 0  
K K N L E Y T A S L L E A V Y I D E T R  
Q I L D T E D E L R E L R S D A V P S E  9 5  
T G C G G G A C T G G C T C G C C T C ~ * = ~ ~ ~ ~ ~ ~ = = A G C A G A C C C G A G C C ~ G G T C G C A G G G C A G  
V R U W L A S T F T Q Q T R A K G R R A  
MCACRRRCCCMCTTC~=~==*~~=T==*=GCTGTGCAGGCTGGGATCTTCGT=GA~= 4 8 0  
G G I T G T T C C G G A G M C G T A T A C C G C T G T G G G T C C C A C C T C T  
E E K P K F R S I V H A V Q A G I F V E  1 3 5  
GTCTCMGMCCTGGACGTCTGGTGCTTCGATGTCTTCTCTTTGMCCGGGCAGCTGATG 6 0 0  
R M F R R T Y T I V G P T Y S T A V H N  
C L K N L D V W C F D V F S L N R A A D  171 
I I C C I \ C G C T C T G A G G A C C A T T G T T T T T ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ = ~ ~ ~ ~ ~ ~ T ~ A T C A G C C G C T  
D H A L R T I V F E L L T R H S L I S R  
T C A A G A T T C C C A C A G T G T T ~ = T ~ ~ ~ ~ ~ ~ ~ T T T T C T G C A G G C C T T A G A G A C A G ~ ~ T * = ~ = = ~  720 
F K I P T V F L M S F L E A L E T G Y G  211 
M T A T M G M C C C T T A C C A C M C C I I T G ~ T  
G C T T C C T G C T C C C C A C i i c c ~ ~ ~ = = T = = A C T G C C T G T C A G A = A ~ ~ = * = = ~ = ~ ~ = ~ C ~ A T C A  8 1 0  
K Y K N P Y H N Q I H A A O Y T Q T V H  
C F L L R T G R V H C L S E I E V L a I  2 5 5  
T C T T C C C C G C I G C C ~ T C C I T G R C T A T G A G C A C ~ ~ ~ = ~ ~ ~ ~ M ~ ~ M ~ A G C T T C C A C A T C C  
I F A A A I H D Y E H T G T T N S F H I  
A G A C C M G T C A G M T G C G C C A T C C T ~ ~ ~ ~ M ~ G A C C G A T C G G T G C T G G A G ~ T C A ~ = ~ = ~  960 
Q T K S E C A I L Y N U R S V L E N H H  2 9 5  
T C A G C T C T G T T T T C C C A A T G A ~ ~ ~ ~ ~ ~ ~ ~ ~ A T G A G A T G M C A T T T ~ T ~ ~ ~ M ~ ~ ~ ~ ~ C ~ ~  
A G G A T G A A T T C G T R G i i C C T G C G G G C C C T G G T C A T T G A ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ = = A = A G A C A T G T  1080 
I S S V F R M M Q D O E H N I F I N L T  
X D E F V E L R A L V I E M V L A T D H  115 
C C T G C C A T T T C C A G C M G T G A A G A C T A T ~ M G A C A G C C C T G C A C C A G C T T ~ ~ ~ ~ ~ ~ ~ =  
A C M A T C C M G G C C C T G T C T C T G C T T C I T G C T C G C  1 2 0 0  
S C H F Q Q V K T I K T A L Q Q L E R I  
A G T G G T C A G T C C A C A G C C G C T G G A C C A A G G C C C T M T G G M G A G T T C T T C C = = = ~ ~ ~ ~ ~ ~  
U K S K A L S L L L H A A U I S H P T K  3 7 5  
Q W S V X S R W T K A L H E E F F R Q C  
A C M G G A G G C A G A G C T C G C C T T G C C C T T C T C C A C T C T = ~ ~ * ~ ~ = ~ ~ = = ~ = = A C A T T G G  1320
T G G C C C A G T C C C A G A T * G G T T T C I \ T T G * C T T C A T T = ~ ~ = ~ ~ ~ ~ ~ ~ ~ ~ T T C T C T G T G C T = ~  
U K E A E L G L P F S P L C D R T S T L  4 1 5  
V A Q S Q I G F I 3 F I V E P T F S Y L  
C T G A T G T G C C A G ~ G A G T G T C C A G C ~ ~ ~ ~ ~ ~ C A G A T G A T G A T T C ~ A A ~ ~ ~ ~ - ~ ~ ~  1410 
T D V A E K S V Q P L T O O O S K S K S  4 5 5  
AGCCCAGCTTCCAGTGGCGCCAGCCTTCTTTAGATGTG~A=~~*~~*~*CCCCMCCCTG 
Q P S F Q W R Q P S L O Y O V G U P N P  
A T G T G G T C A G T T T C C C C T C C A C C T C C A C C M = T A C A T T C M G A C M T R R R C A ~ M ~ ~ = ~ ~  1560 
U V V S F R S T W T K Y I Q E N K Q K W  4 9 5  
A C G M C G G G C A G C G A G T G G C A T C A C C M ~ ~ A G A T G T C C A T T G A T G M C T ~ ~ ~ ~ ~ ~ ~ ~ ~ T G  
A G G I V \ G M G C C C C A T C C T C C C C T G C I G ~ ~ A G R T C R C C I T C T G G A T T  1680 
K E R A A S G I T N Q M S I D E L S P C  
A G G C A A C T C C G A G C T G G C C A G G T C C T C R C T G * G T C C A M G T ~ ~ ~ = ~ * ~ ~ ~ = ~ ~ ~ ~ ~ = A ~ T  
E E E A P S S P A E D E H N Q N G N L D  515 
ATCC*TCIICGACTCGTTCCCCCATCTGCTCCAAGGGA=~=TGTTGGTTGTGATAGA~~=* 
GCCCACCTGIGIGCCAMTGTTGGAGCIGGT 
FIG. 4. Nucleotide sequence and predicted amino acid se- 
quence of the rat 63-kDa CaM-PDE clone Arb 5.  Stop codons 
upstream of the first ATG codon and at the  end of the coding sequence 
are marked with asterisks. The nucleotide and amino acid residues 
are numbered on  the right. 
. g  of PDEs by PCR 
tem has an extremely low level of transcription of the cloned 
insert prior to induction by IPTG. Host cells containing 
pET3b with and  without the  PDE sequence insert were in- 
cubated with IPTG for 2.5 h  and  then lysed. The extract was 
assayed for PDE activity in the absence and presence of 
calmodulin and calcium. cGMP hydrolysis was assayed as  the 
host  bacteria had an active endogenous CAMP-specific PDE 
activity that created  a high background when CAMP hydrol- 
ysis  was assayed (data  not shown). Extract from host carrying 
only the pET3b vector without insert had low base line cGMP 
PDE hydrolytic activity that did not increase in  the presence 
of calcium and calmodulin (Table I).  PDE hydrolytic activity 
in extract from host expressing pET3b clones 9  and 16 was 
increased &fold over base line in the absence of calcium and 
calmodulin and was further  enhanced 2-3-fold in the presence 
of calcium and calmodulin. This demonstrates that  the Arb 5 
clone encodes a CaM-PDE. The molecular radius of the 
expressed protein was estimated by its migration in polyacryl- 
amide gel electrophoresis. Induction of expression of the CaM- 
PDE by IPTG led to appearance of a 63-kDa protein  band 
detectable both by Coomassie Brilliant Blue staining  and by 
[35S]methionine incorporation that was not  present in non- 
induced host extract  (data  not shown). 
DISCUSSION 
In the past several years, the existence of a remarkable 
heterogeneity of mammalian PDEs  has become evident. The 
role of multiple PDEs in an organism, a  tissue,  and even a 
single cell is not yet understood. It has been postulated that 
there may  be differential regulation of transcription  and ac- 
tivity, and differential localization of these various PDEs  (4). 
Many  PDE isozymes have now  been characterized biochemi- 
cally, but  the low abundance, labile activity,  and biochemical 
similarity of many of the isozymes has limited the progress 
possible by strictly biochemical approaches. We report here a 
method using degenerate PCR primers to identify some of the 
different PDE forms expressed at a given time in a tissue of 
interest. 
From rat liver, we have retrieved clones which correspond 
to each of the four members of the  CAMP-PDE family previ- 
ously isolated from rat  testis (12, 13).  This same preparation 
of rat liver poly(A)+ RNA in Northern blots revealed only the 
presence of transcripts of ratPDE3  and  ratPDE4 (12, 13). A 
novel cGS-PDE clone was also isolated from rat liver cDNA. 
Two PDE clones were isolated from the mouse K30a T- 
lymphoma cell line. A single CAMP-PDE clone, corresponding 
to  ratPDE3, was found along with a novel clone that encodes 
a peptide identical to a  portion of the bovine 63-kDa CaM- 
PDE.  These clones demonstrate, at least at  the mRNA  level, 
that both  a  CAMP-PDE  and  a  CaM-PDE  are expressed si- 
multaneously in these T-lymphocyte-derived cells. There 
have been conflicting reports of the presence of one or mul- 
tiple PDE isozymes in lymphoid cells (22, 36),  and no CaM- 
PDE activity has been detected in the K30a cell line (26). 
Perhaps this enzyme is expressed under these cell culture 
TABLE I 
Expression of PDE clone Arb 5 in E. coli BL21 lDE3) DLVSS 
cCMP phosphodiesterase activity" 
Expression vector 
- Calrnodulin + Calrnodulin 
pET3b vector alone 
pET3b/Arb 5 9 
0.08 0.02 
pET3b/Arb 5 16 
0.42 0.86 
0.43 1.36 
' Expressed as pmol of cGMP hydrolyzed/min using lysate from 
4.5 X lo7 cells with 1 ,.LM cGMP, and 500 ng/ml calmodulin and 2 
mM CaCI2,  where indicated. 
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conditions, but requires a biochemical modification before it 
is enzymatically active. From the human hypothalamus, 
clones corresponding to a  cGS-PDE  and the  rat CAMP-PDE, 
ratPDE2, were amplified. This  latter  human clone is identical 
to a  portion of the  CAMP-PDE clone previously isolated from 
a human monocyte library (16). The human hypothalamus 
was also found to have a PDE  transcript with sequence very 
similar to  the K-17 sequence suggesting that a 63-kDa CaM- 
PDE is present in human brain. 
All  of the clones isolated to  date  are from three of the five 
families of PDEs. The cGMP-PDE family members have been 
found to be present only in photoreceptors, lung, and platelets 
(38, 39) and thus might not occur in the tissues we have 
examined. However, members of the cGI-PDE family are 
known to be expressed both  in rat liver (40)  and  in K30a cells 
(26). Possibly, the  cGI-PDEs do not  share homology with the 
other PDE families in the regions from which the PCR 
primers were designed. Alternatively, the cGI-PDEs might 
share  these regions of homology, but  the PCR  primers  are  not 
sufficiently degenerate, especially at  the critical 3‘ ends, to 
allow amplification of the cGI-PDEs. The cG1-PDEs are 
extremely low abundance isozymes, and  it is also possible that 
these  PCR  primers do amplify the cDNA for these  PDEs but 
that more amplified DNA fragments would need to be 
screened before one for this  PDE would  be isolated. 
The mouse K-17 clone was used as  a probe to screen a rat 
brain library to isolate a corresponding full-length clone, Arb 
5. We  believe that our Arb 5 clone represents the  rat 63-kDa 
CaM-PDE because: 1) the clone encodes a  protein of actual 
molecular weight 61,325 that has CaM-PDE enzymatic activ- 
ity when expressed in bacteria, 2) this cDNA is abundant in 
a mitogenically active mouse lymphocyte cell line and in rat 
brain, which matches the tissue distribution of the 63-kDa 
CaM-PDE,  and 3) this clone encodes a  protein that has 97% 
amino acid identity (517 out of 535) with the bovine 63-kDa 
CaM-PDE that  is described in  the accompanying report (25). 
The  rat 63-kDa CaM-PDE  has 1 additional amino acid com- 
pared with the bovine enzyme (Arg-Arg-Ala at residues 113- 
115 compared with Pro-Ser).  Both species encode their mes- 
sage on a 3-4 kb  mRNA. 
Several deductions can be made about the biochemical 
properties of the 63-kDa CaM-PDE based on the predicted 
amino acid sequence. This protein does share 57% overall 
amino acid identity with the bovine 61-kDa CaM-PDE with 
over 70% identity in the putative  catalytic domain between 
the PCR primers, PDE-5’  and PDE-3’, demonstrating that 
these  proteins  are closely related. The  rat 63-kDa CaM-PDE 
has a  NH2-terminal domain encompassing amino acids 27-48 
which is only 54% identical to  the well-characterized calmod- 
ulin binding domain of the 61-kDa CaM-PDE  (7). However, 
these rat 63-kDa CaM-PDE amino acid residues are also 
capable of forming a basic amphipathic a helix, a  hallmark of 
CaM-binding domains, and  thus  this  PDE appears to have a 
unique CaM-binding domain at this site. The bovine 59- and 
61-kDa  CaM-PDEs differ only in their CaM-binding domains, 
and this difference is therefore postulated to confer their 
differential sensitivity to activation by calcium and calmod- 
ulin (21). The distinct CaM-binding domain of the  rat 63- 
kDa  CaM-PDE, which is identical to  that of the bovine 63- 
kDa isozyme (25), probably gives these isozymes a unique 
sensitivity to calcium and calmodulin. The carboxyl termini 
(residues 437-535  of the  rat 63-kDa protein  and residues 428- 
525 of the bovine 61-kDa protein)  are completely different, 
reminiscent of the structure of the members of the CAMP- 
PDE family that are highly homologous but have divergent 
sequence at  the carboxyl terminus. Possibly, these regions are 
involved in regulation of PDE activity by phosphorylation. 
Biochemical evidence suggests that  the bovine 63-kDa CaM- 
PDE is regulated by phosphorylation with CaM-dependent 
protein kinase I1 and  that  the 61-kDa CaM-PDE is regulated 
by phosphorylation by protein kinase A (20). The deduced 
amino acid sequence of our clone contains three Arg-X-X- 
Ser/Thr CaM-dependent protein kinase I1 phosphorylation 
consensus sequences within the carboxyl-terminal 125 amino 
acids (residues 414, 465, and 501) and a fourth site in the 
NH2-terminal domain at amino acid residue 143. There  are 
also three casein kinase I1 consensus phosphorylation sites in 
the COOH terminus (residues 447, 508, 513, and 522) as well 
as in the NH, terminus at residue 80. There is also a possible 
protein kinase A phosphorylation site at residue 141. How- 
ever, there is no evidence that casein kinase I1 phosphorylates 
this enzyme and  there is evidence against protein kinase A 
regulation of the 63-kDa enzyme (20). 
The CaM-PDEs  are allosterically activated by binding of a 
calcium-CaM complex. This complex appears to activate 
these isozymes by functionally displacing an inhibitory do- 
main as removal of the NH2-terminal domain by limited 
proteolysis yields a constitutively activated, CaM-independ- 
ent polypeptide (37). The CaM-PDEs  are highly susceptible 
to proteolysis during purification, and thus most preparations 
have significant CaM-independent PDE activity. This CaM- 
independent background activity is the likely explanation for 
our expression studies that show significant PDE activity 
before addition of calcium and CaM and only a 2-3-fold 
activation after  their addition. 
The PCR-based approach to cloning PDEs  that we have 
described is a general method for cloning PDEs of diverse 
type. This method should facilitate the currently difficult 
approach to defining the range of PDE isozymes that are 
expressed in a single tissue or cell type. With  the sensitivity 
of PCR in amplifying minute  quantities of cDNA, it should 
even be possible to evaluate the  PDEs present in a single cell. 
A general method for cloning mammalian PDEs is also valu- 
able for developing PDE probes across species lines to facili- 
tate  the cloning and study of homologous PDEs from different 
species. Finally, molecular cloning of additional mammalian 
PDEs will help define the variety of isozymes present within 
each PDE family and will provide valuable tools for investi- 
gating the roles of these isozymes in regulation of intracellular 
concentrations of the cyclic nucleotides. 
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